z-logo
Premium
Polymorphism of TLR 5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection
Author(s) -
Cao Lina,
Zhang Tong,
Zhu Junping,
Li Aixin,
Zheng Kai,
Zhang Nan,
Su Bin,
Xia Wei,
Wu Hao,
Li Ning,
He Qiushui
Publication year - 2017
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/apm.12707
Subject(s) - hepatocellular carcinoma , genotype , immunology , hepatitis b virus , liver disease , toll like receptor , cirrhosis , medicine , hepatitis b , disease , virus , innate immune system , biology , virology , gene , immune system , genetics
Toll‐like receptors ( TLR s) play a crucial role in innate and adaptive immunity, protecting the host from viral pathogens. Studies have implicated that TLR 5 is associated with various diseases such as autoimmune and inflammation related diseases. However, little is known about the relationship between TLR 5 and hepatitis B virus ( HBV ) infection. We studied the effect of TLR 5 gene polymorphisms on susceptibility to and disease progression of chronic hepatitis B ( CHB ) infection in Chinese. Blood samples were taken from 636 patients with CHB , HBV ‐related liver cirrhosis ( LC ) or hepatocellular carcinoma ( HCC ) and 273 controls. Polymorphisms of TLR 5 (1775A>G rs2072493 and 1846T>C rs5744174) were analyzed by PCR ‐based sequencing. No difference in genotypic and allelic frequencies of TLR 5 rs2072493 and rs5744174 was observed between patients and controls. Significant difference was found in frequency of TLR 5 rs5744174 TT genotype between men with CHB and LC (p = 0.035). Frequency of TT genotype of TLR 5 rs5744174 in patients positive for HB eAg was increased from 53.2% in patients with CHB to 74.1% in those with HCC (p = 0.024). Our results indicate that in Chinese genetic variation of TLR 5 may be not a determinant of susceptibility to HBV ‐related diseases but may play a role in development of HBV ‐related severe liver diseases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom